(Q34274940)

English

Circumventing cancer drug resistance in the era of personalized medicine

scientific article

In more languages

default for all languages

No label defined

No description defined

edit

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

22585993

retrieved

1 August 2017

title

Circumventing cancer drug resistance in the era of personalized medicine (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

22585993

retrieved

1 August 2017

main subject

personalized medicine

1 reference

2

Pasi A Jänne

1 reference

stated in

Europe PubMed Central

PubMed publication ID

1 August 2017

1

Levi A Garraway

1 reference

stated in

Europe PubMed Central

PubMed publication ID

22585993

retrieved

1 August 2017

publication date

28 February 2012

1 reference

stated in

Europe PubMed Central

PubMed publication ID

1 August 2017

1 reference

Europe PubMed Central

PubMed publication ID

22585993

retrieved

1 August 2017

volume

2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

22585993

retrieved

1 August 2017

issue

3

1 reference

stated in

Europe PubMed Central

PubMed publication ID

22585993

retrieved

1 August 2017

page(s)

214-226

1 reference

stated in

Europe PubMed Central

PubMed publication ID

22585993

retrieved

1 August 2017

cites work

Melanomas acquire resistance to B-RAF(V600E) inhibition by RTK or N-RAS upregulation

1 reference

24 May 2022

https://opencitations.net/index/coci/api/v1/citations/10.1038/NATURE09626

MET amplification leads to gefitinib resistance in lung cancer by activating ERBB3 signaling

1 reference

24 May 2022

https://opencitations.net/index/coci/api/v1/citations/10.1126/SCIENCE.1141478

Acquired resistance to BRAF inhibitors mediated by a RAF kinase switch in melanoma can be overcome by cotargeting MEK and IGF-1R/PI3K

1 reference

24 May 2022

https://opencitations.net/index/coci/api/v1/citations/10.1016/J.CCR.2010.11.023

Preexistence and clonal selection of MET amplification in EGFR mutant NSCLC.

1 reference

24 May 2022

https://opencitations.net/index/coci/api/v1/citations/10.1016/J.CCR.2009.11.022

Identifiers

DOI

10.1158/2159-8290.CD-12-0012

1 reference

stated in

Europe PubMed Central

PubMed publication ID

22585993

retrieved

1 August 2017

PubMed publication ID

22585993

1 reference

stated in

Europe PubMed Central

PubMed publication ID

22585993

retrieved

1 August 2017

(Q34274940)

Circumventing cancer drug resistance in the era of personalized medicine

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)